Assistive Devices for empowering disAbled People through robotic (Q4295345): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
(‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates)
Property / contained in NUTS
 
Property / contained in NUTS: East Kent / rank
 
Normal rank

Revision as of 13:11, 17 June 2022

Project Q4295345 in France, United Kingdom
Language Label Description Also known as
English
Assistive Devices for empowering disAbled People through robotic
Project Q4295345 in France, United Kingdom

    Statements

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    6,607,019.3 Euro
    0 references
    9,765,647.8 Euro
    0 references
    67.66 percent
    0 references
    29 November 2016
    0 references
    30 June 2022
    0 references
    INSTITUT DE RECHERCHE EN SYSTEMES ELECTRONIQUES EMBARQUES
    0 references

    49°53'56.98"N, 2°17'53.77"E
    0 references

    50°15'58.43"N, 5°5'32.06"W
    0 references

    51°31'19.96"N, 0°6'52.99"W
    0 references

    51°6'59.26"N, 0°11'49.56"W
    0 references

    51°16'21.50"N, 0°29'12.37"E
    0 references

    51°15'58.36"N, 1°5'11.90"E
    0 references

    48°5'47.26"N, 1°37'59.30"W
    0 references

    51°17'51.29"N, 1°3'52.52"E
    0 references

    48°7'29.39"N, 1°38'0.82"W
    0 references

    48°6'19.55"N, 1°39'56.34"W
    0 references

    51°16'48.90"N, 1°5'23.21"E
    0 references

    50°24'59.80"N, 4°6'56.66"W
    0 references

    49°23'6.43"N, 1°4'30.47"E
    0 references

    49°26'15.00"N, 1°6'34.81"E
    0 references

    49°11'15.97"N, 0°18'23.04"W
    0 references
    Ageing societies and chronic disabilities are irrevocable trends in EU which usually result in a loss of autonomy and a breakdown of social relations. In some cases, the use of Electrical Powered Wheelchair (EPW) is the only way to provide autonomy and improve social inclusion (62/10000 people in FR - 200/10000 in UK). At present many people with complex disabilities face increased isolation due to loss of independent mobility because of difficulties of getting assessed for provision of an EPW and the availability of an appropriate EPW. In response to these trends, studies highlight the key role of innovative Assistive Technologies (AT), including Social Assistive Robotics (SAR) and smart EPW (JRRD 2008), as effective tools to empower disabled and aged people and improve social inclusion. But barriers exist in the uptake of AT (standardization, interoperability, limited involvement of users, lack of specialist training for health professionals and funding models). To overcome these barriers, the project strategy will rely on a framework of innovation including developments from TRL 4 to 8 and training in AT. Cost-effective products and standardization will be a focus in the developments to facilitate the deployment of the solutions to the market. Pre/post trial questionnaires will be used throughout the project to measure the added-value of the following innovative outputs and to continuously improve them to meet stakeholder’s needs. 1) Smart EPW to compensate for user disabilities through driving assistance technologies and report users’ health through connection with internet. This system will benefit severely disabled users and enable health professionals to monitor changes in user health (CH.#7). 2) EPW Simulator platform using virtual reality. This will give the user an immersive experience of the smart EPW and train them to drive in everyday life (CH.#7). Professionals will assess the suitability of the EPW for particular patients and environments and gain understanding from the user perspective. 3) Training of healthcare professionals in AT. This novel training provision addresses a gap in the current healthcare education. Project platforms (EPW simulator + smart EPW) will be captured in training protocols for the benefit of users and healthcare providers (CH.#8). 4) Formalized agreements between research institutions and companies built through 20 events ranging from local to international meetings for promoting and disseminating ADAPT’s results, creating synergies, identifing points ofconvergence for common studies so as to boost R&D and favor the spread of innovative ADAPTs AT to the market (CH.#1,2,3). The cross-border benefit of the proposed multidisciplinary consortium goes beyond the complementary technical skills to embrace the different cultural, regulatory and training environments building a fruitful context of collaboration to achieve greater convergence towards increasing market adoption of these AT. (English)
    0 references

    Identifiers

    0 references